跨物种绘制寄生虫线粒体蛋白组,发现33个潜在广谱药物靶点家族
Mapping parasite mitochondria reveals ancient pathways and dozens of potential new drug targets
由HHMI研究员Vamsi Mootha牵头、25名科学家组成的联合团队用四年时间绘制了Giardia、Acanthamoeba、锥虫、Leishmania和Babesia五种寄生虫(另加一种植物)的线粒体蛋白组,成果发表于9篇论文。
Cut the power, and the machine stops. That was part of the motivation behind a four-year effort to map all the proteins in the mitochondria—often called the powerhouse of the cell—of the parasites that cause sleeping sickness, giardiasis, leishmaniasis and babesiosis, diseases that together affect nearly a billion people every year.
Led by HHMI investigator Vamsi Mootha, a consortium of 25 scientists across the Harvard T.H. Chan School of Public Health, Harvard Medical School, the Broad Institute, Massachusetts General Hospital and Boston University mapped the mitochondrial proteome—the organelle's full set of proteins—across five deadly parasites (and one plant, for good measure), spanning a billion years of evolution.
The results, published in nine papers, point toward promising new drug candidates. Several of the disease-causing parasites share ancient mitochondrial machinery that human mitochondria lost long ago—machinery that could become the basis for drugs that target multiple pathogens at once.
The studies also shed light on how these organisms developed some highly unusual properties—many of which defy old assumptions about mitochondria. Among the evolutionary traits Mootha's group examined, some mitochondria could run without oxygen, while others had lost their signature DNA altogether. By tracing mitochondrial evolution back a billion years, the team also reconstructed what one of the earliest mitochondria may have looked like.
Many experts, one method
The team mapped mitochondrial proteomes of five eukaryotic organisms—Giardia, Acanthamoeba, trypanosomes, Leishmania and Babesia.
"This has been a dream project of mine for decades," says Mootha, who previously led efforts to map mitochondrial proteomes in humans and mice.
He convened experts across many fields: parasitology, mitochondrial biochemistry, mass spectrometry, structural biology and computation. The group spent more than a year just testing methodologies, searching for a single workflow accurate and adaptable enough to apply uniformly across every organism, so the results could be trusted and reproduced.
They landed on a technique called protein correlation profiling: breaking each organism's cells into pieces, then using mass spectrometry to track which proteins consistently sorted with known mitochondrial components. Proteins that moved in lockstep with the mitochondria, batch after batch, could be confidently added to the parts list—even ones no one had ever linked to the organelle before.
The hunt for a pan-parasitic drug
Targeting mitochondria has already proven an effective strategy against parasites. Atovaquone, for instance, works by blocking a mitochondrial protein in Plasmodium falciparum, the parasite responsible for the deadliest form of malaria.
Armed with this proof of concept—mitochondria as validated drug targets—the consortium looked for protein families shared across the mitochondria of trypanosomes, Leishmania, Acanthamoeba and Babesia. A viable drug target would also need to be absent from human mitochondria to ensure it won't harm patients along with the parasite. The team found 33 such protein families shared across two or more of the parasites: promising candidates for a drug that could treat multiple diseases at once.
Mootha is careful to note that these findings are still early-stage. There's a long road between identifying a candidate target and delivering a safe drug to patients—but it's a promising first step.
Redefining the cellular powerhouse
The new research challenges our understanding of mitochondria.
"Our textbook view comes from the human and yeast versions—aerobic powerhouses that carry their own DNA," Mootha explains. "That's true across much of the tree of life, but it's only part of the story."
Studying more "exotic" species revealed organelles that defy this textbook picture. Take genome retention: mitochondria are famous for carrying their own small genome, transmitted from mother to child in humans. But Giardia's mitochondria have lost that genome entirely.
Scientists already knew that the organelle's only confirmed function was iron-sulfur cluster synthesis. Now, having mapped its full mitochondrial proteome, the team found that the organelle contains 59 proteins in total—and more than half have functions that are still unknown, though they likely don't add up to anything worthy of the "powerhouse of the cell" title.
Acanthamoeba's mitochondria, by contrast, turned out to be unusually complex. They run on oxygen, like ours, but also carry a backup power source: an enzyme called hydrogenase. When oxygen runs low, this enzyme lets the mitochondria combine protons and electrons to produce hydrogen gas instead of water—another example of an organelle that breaks the aerobic mold.
"A lot of these pathogenic protists have common pathways that were, evolutionarily, part of the first mitochondria on the planet. Our human mitochondria have lost them," Mootha explains. "I never expected this, but in some ways, the human mitochondria are actually the oddball."
Looking back, looking forward
For the consortium, the six organisms were never meant to be the endpoint—they were a launchpad. Using their new data, the team trained an AI model to predict the mitoproteomes of nearly 200 eukaryotes, many of which aren't experimentally traceable.
This let them reconstruct the gains and losses that shape modern mitochondria and better understand what happens when a lineage loses its signature DNA. They found that this loss occurred independently in five different lineages—and in each case, the mitochondria didn't just lose their DNA; the rest of the organelle shrank too, sometimes dramatically.
Combining decades of existing mitochondrial research with their own, the team built a model of the mitochondrion belonging to LECA, the last common ancestor of all eukaryotes alive today. The result was surprising: Rather than a simple, stripped-down organelle, LECA's mitochondrion appears to have been sophisticated and metabolically flexible, capable of generating energy whether or not oxygen was around.
Mootha and his collaborators hope the full data set—all publicly available—becomes a durable resource for the field, helping expedite future researchers' efforts to map other mitochondrial proteomes.
"The goal of these inventories isn't just to have inventories," Mootha says. "It's to make really awesome science possible."
Publication details
Michael Z. Chen et al, Comparative analysis of mitochondrial proteomes across the tree of life, Cell (2026). DOI: 10.1016/j.cell.2026.08.029
Jonathan A. Stefely et al, Mitochondrial proteome of Acanthamoeba delineates aerobic and anaerobic pathways dynamically regulated by oxygen, Cell (2026). DOI: 10.1016/j.cell.2026.08.056
Minsoo Kim et al, A high-confidence plant mitochondrial proteome via protein correlation profiling, Cell (2026). DOI: 10.1016/j.cell.2026.08.027
Cora N. Betsinger et al, Mitochondrial proteome of the apicomplexan Babesia divergens, Current Biology (2026). DOI: 10.1016/j.cub.2026.08.072
Manish Goyal et al, A high-confidence inventory of the proteins in the mitochondrion-related organelle of Giardia, Current Biology (2026). DOI: 10.1016/j.cub.2026.07.074
Andres F. Vacas et al, Lineage-specific innovations expand mitochondrial proteomes in kinetoplastids, Molecular Cell (2026). DOI: 10.1016/j.molcel.2026.08.032
Michelle Y. Fry et al, Acanthamoeba ATP synthase structure reveals the TCA cycle is tethered to OXPHOS, Cell (2026). DOI: 10.1016/j.cell.2026.08.057
Jonathan A. Stefely et al, Acanthamoeba castellanii genome reannotation and multi-omic encystation profiling reveals cyst wall proteins and carbohydrate-active enzymes, Cell Press Blue (2026). DOI: 10.1016/j.cpblue.2026.100125
Md Solayman et al, Conserved and divergent mitochondrial assemblies in kinetoplastid parasites, Molecular Cell (2026). DOI: 10.1016/j.molcel.2026.08.031
Journal information: Cell Press Blue , Cell , Current Biology , Molecular Cell
Key medical concepts
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Mapping parasite mitochondria reveals ancient pathways and dozens of potential new drug targets (2026, October 3) retrieved 3 October 2026 from https://medicalxpress.com/news/2026-10-parasite-mitochondria-reveals-ancient-pathways.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com